摘要
继发性甲状腺功能减退症(甲减)是131I治疗甲状腺功能亢进症(甲亢)后最重要的并发症。早发甲减与晚发甲减的发生机制不尽相同,有待进一步研究。甲减替代治疗是用动物甲状腺提取物还是用L鄄T3和L鄄T4复合制剂,目前尚无肯定回答。
The secondary hypothyroidism is the most important intercurrent disease after radioiodine therapy. The early hypothyroidism and the late hypothyroidism are incompletely different in pathogenesis. It needs researching further. There has not yet been an affirmable answer to choose the distillates from animal hypothyroid extract or complex preparation of levo-thyroxine in replacement treatment.
出处
《国外医学（放射医学核医学分册）》
2004年第6期265-266,共2页
Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
